ArticleJournal of infection and public health2021

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents.

Mohammad Z Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.